SPOTLIGHT: GSK initiates staff cuts in NC

GlaxoSmithKline has started layoffs in North Carolina, where some 6,000 people work for the company; GSK won't say how many staffers will be cut or where. The cutbacks are part of a company-wide restructuring announced in October. Report

Suggested Articles

Pfizer's diagnosis-focused launch strategy for Vyndaqel and Vyndamax is paying off with the meds reaching thousands of patients already.

Pfizer terminated a slew of trial cohorts testing Bavencio in combination with its own experimental drugs, as well as one monotherapy trial.

With its Eli Lilly-partnered Olumiant nearing filing in atopic dermatitis, Incyte's other JAK med Jakafi is also looking for a win in that indication.